LETTER TO THE EDITOR


COVID-19 and HIV-associated Nephropathies: Double Whammy



Debamita Sutar1, #, Nobendu Mukerjee2, 3, Dattatreya Mukherjee4, Swastika Maitra5, Abhijit Dey6, Athanasios Alexiou4, 5, *, Arabinda Ghosh9, #
1 Department of Microbiology, Sarsuna College, University of Calcutta, Calcutta, India
2 Department of Microbiology; Ramakrishna Mission Vivekananda Centenary College, West Bengal, Kolkata- 700118, India
3 Department of Health Sciences, Novel Global Community Educational Foundation, Hebersham NSW 2770, Australia
4 Raiganj Government Medical College and Hospital, West Bengal, India
5 Department of Microbiology, Adamas University, Barasat - Barrackpore Road, 24 Parganas North, Jagannathpur, West Bengal 700126, India
6 Department of Life Sciences, Presidency University, Kolkata, West Bengal-700073, India
7 Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham NSW 2770, Australia
8 AFNP Med, Wien 1030, Austria
9 Department of Botany, Microbiology Division, Gauhati University, Assam, India


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 423
Abstract HTML Views: 358
PDF Downloads: 235
ePub Downloads: 173
Total Views/Downloads: 1189
Unique Statistics:

Full-Text HTML Views: 278
Abstract HTML Views: 233
PDF Downloads: 186
ePub Downloads: 139
Total Views/Downloads: 836



Creative Commons License
© 2022 Sutar et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Science and Engineering, Novel Global Community Educational Foundation, Australia; E-mail: alextha@yahoo.gr
#These authors contributed Equally.


Abstract

The number of COVID-19-associated nephropathies (COVAN) rapidly increased before the fourth wave of the COVID-19 pandemic. Similarities and common lesions with the HIV-associated nephropathy (HIVAN) remarkably affect mostly African Americans positive for the APOL1 risk variants; therefore, these cases must be prioritized in new targeted clinical trials.

Keywords: Cyclin-dependent kinase inhibitors, HIV-1, HAART, Polymorphism, HIVAN, COVAN, Glomerulosclerosis.